Varex Imaging Corp Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $865M+6.7% YoYTTM through 3 Jul 2026
Net Income $22.1MTTM through 3 Jul 2026
Free Cash Flow -$20.2MTTM through 3 Jul 2026
Margins
| Current | |
|---|---|
| Gross Margin | 34.4% |
| EBITDA Margin | 11.5% |
| Operating Margin | -3.3% |
| Net Margin | 2.6% |
Returns
-14.5%ROE
-6.4%ROA
3.0%ROIC
Balance Sheet Health
Debt / Equity0.76x
Current Ratio3.89x
Net Debt$212.5M
Cash & Equivalents$99.2M
Quality Metrics
Altman Z-Score2.29
Piotroski F-Score7 / 9
FCF Margin-2.3%
Rule of 40-1.6
Earnings-Beat Rate75.0%
Multi-Year Trend
RevenueFY2025: $844.6M
Diluted EPS$0.53TTMFY2025: $-1.70
Dividend
No dividend
Capital Allocation
R&D Spend$91.4M
Capex Intensity3.6%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Medical | $592M | +1.8% | View detailsSubject to ongoing macroeconomic challenges and tariff impacts in China, with production shifting to India to mitigate risks. |
| Industrial | $253M | +10.3% | View detailsExpected to continue growing driven by cargo security systems and photon counting detectors. |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.